Ross Dobinson has extensive corporate advisory and investment banking
experience. Ross has also taken an entrepreneurial role in the commercialisation
of technologies in a range of fields, including: agricultural science,
pharmaceuticals, environmentally-friendly packaging, medical
devices, drug delivery technology and nutriceuticals. Ross has experience in company formation, seed, mezzanine
and IPO funding, specialising in the life sciences sector, where
he has been a founding director, investor and executive of listed
and unlisted companies.
Commencing as a chartered accountant with Hungerfords, Ross has held positions as a Director of the listed stockbroking firm
of Jacksons Limited, Head of Corporate Advisory Services at the
stockbroking firm operated by National Australia Bank Limited (A.C.
Goode & Co. Ltd), Director of National Australia Corporate Advisory
Limited, and Director of Corporate Advisory of Dresdner Australia Proprietary Limited.
Ross has taken two highly successful biotechnology companies
from pre-seed stage to listed status with a current market capitalisation of over $275
million. In addition, Ross has been involved in venture capital
initiatives in Australia, Europe and the United States.
Ross has a Bachelor of Business Degree from Queensland University of Technology. He is currently
Horizon Science Pty Ltd
Micronix Pty Ltd
Diagnotech Pty Ltd
Farm By Nature Pty Ltd
TPI Enterprises Ltd
Etech Group International
He is also a Director of:
Starpharma Holdings Limited
Origin Capital Limited
PharmaQest Pty Ltd
Healthfarm Fine Foods Pty Ltd